SIRT1 and cancer: Further research has shown that liver proliferation and cancer progression are driven by the downregulation of SIRT1 and its downstream effector, PGC-1α, which is suppressed by the CCAAT/enhancer binding protein β-histone deacetylase 1 complex (Jin et al., 2013).